| |
|
|
|
Tenax Therapeutics Inc.  
|
|
1.24 0.07 (0.06%) |
01-15 16:00 |
|
Open: |
1.16 |
Pre close: |
1.17 |
Target:
|
1.67 
|
|
High: |
1.45 |
Low: |
1.15 |
Resistance:
|
1.43
1.68
|
|
Volume: |
2,017,159 |
Market Cap: |
2M |
Support:
|
1.03
0.86
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.17
|
MACD |
MACD(12,26):
|
-0.27  |
|
MA(20): |
1.17 |
Signal(12,26,9): |
-0.36 |
|
MA(100): |
3.74 |
Stochastic Oscillator |
%K(14,3):
|
38.05 |
|
MA(250): |
5.40 |
%D(3): |
33.70 |
|
Average Volume(K) |
3-Month: |
54918
|
52-Week |
High:
|
12.63 |
|
10-Days: |
93273 |
Low: |
1.03 |
|
RSI |
RSI(14):
|
36.62 |
Change(%): |
-83.5 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-79.0 |
Shares Out. (M) |
3.02 |
|
EPS Est. Current Year |
-0.360 |
Return on Assets (ttm) |
-72.5 |
Shares Float (M) |
1.37 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.080 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
6.80 |
|
Forward EPS |
-2.633 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.690 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.80 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.58 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.71 |
P/CF |
-0.67 |
|
|
|
|
|
|
